Cover Image

Is metabolic syndrome a risk factor in hepatectomy?: A meta-analysis with subgroup analysis for histologically confirmed hepatic manifestations

Metabolic syndrome (MetS) is a risk factor in surgery. MetS can progress to metabolic (dysfunction)-associated fatty liver disease (MAFLD), a vast-growing etiology of primary liver tumors which are major indications for liver surgery. The aim of this meta-analysis was to investigate the impact of Me...

Full description

Saved in:
Bibliographic Details
Main Authors: Murtha-Lemekhova, Anastasia (Author) , Fuchs, Juri (Author) , Feiler, Svenja (Author) , Schulz, Erik R. (Author) , Teroerde, Miriam (Author) , Kalkum, Eva (Author) , Klotz, Rosa (Author) , Billeter, Adrian (Author) , Probst, Pascal (Author) , Hoffmann, Katrin (Author)
Format: Article (Journal)
Language:English
Published: 28 January 2022
In: BMC medicine
Year: 2022, Volume: 20, Pages: 1-13
ISSN:1741-7015
DOI:10.1186/s12916-022-02239-x
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s12916-022-02239-x
Get full text
Author Notes:Anastasia Murtha-Lemekhova, Juri Fuchs, Svenja Feiler, Erik Schulz, Miriam Teroerde, Eva Kalkum, Rosa Klotz, Adrian Billeter, Pascal Probst and Katrin Hoffmann
Description
Summary:Metabolic syndrome (MetS) is a risk factor in surgery. MetS can progress to metabolic (dysfunction)-associated fatty liver disease (MAFLD), a vast-growing etiology of primary liver tumors which are major indications for liver surgery. The aim of this meta-analysis was to investigate the impact of MetS on complications and long-term outcomes after hepatectomy.
Item Description:Gesehen am 09.09.2022
Physical Description:Online Resource
ISSN:1741-7015
DOI:10.1186/s12916-022-02239-x

Similar Items